Download
HTML Embed
HTML EMBED
Click to Copy

Latest Episodes

Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
Download
HTML Embed
HTML EMBED
Click to Copy
This Is Uncomfortable
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report
Download
HTML Embed
HTML EMBED
Click to Copy
Marketplace Morning Report

The connection between the market and FDA

Dan Gorenstein Aug 18, 2015
Share Now on:
HTML EMBED:
COPY

The Food and Drug Administration is expected to rule Tuesday on what’s come to be called Viagra for women, a drug that purports to enhance a woman’s sexual desire.  

The FDA has twice previously rejected the application on grounds that it carries modest benefits and potentially significant side effects, like lowering blood pressure and fainting. Risk is heightened when using other medications including birth control. But an advisory committee has endorsed the pill, which, yes, is pink.

Groups including the National Organization for Women have thrown their weight behind a campaign called “Even the Score.” That effort has financial support from Sprout Pharmaceuticals, the company manufacturing the drug. Sprout recently flew a patient out to testify in front of the FDA.

Those moves have critics, including Dr. Adriane Fugh-Berman, a professor at Georgetown University.

“This may set a precedent of risky drugs being approved based on public relations campaigns rather than science,” she says.

The pharmaceutical industry certainly has used a patient’s story to make money before this. Emory University’s David Howard says what’s interesting is how important that story has become.

“There is a movement in medicine away from top-down paternalism,” he says. “There is a push to listen to the patient and let them dictate the terms on which a treatment is going to be judged.”

Whether the pill stimulates anyone’s libido, if this drug takes off, it could drive home the point there’s a market for woman who want to improve their sex lives; a market that’s largely been ignored.

If you’re a member of your local public radio station, we thank you — because your support helps those stations keep programs like Marketplace on the air.  But for Marketplace to continue to grow, we need additional investment from those who care most about what we do: superfans like you.

Your donation — as little as $5 — helps us create more content that matters to you and your community, and to reach more people where they are – whether that’s radio, podcasts or online.

When you contribute directly to Marketplace, you become a partner in that mission: someone who understands that when we all get smarter, everybody wins.